Dr Reddy's gets EIR for Hyderabad facility
New Delhi: Drug firm Dr. Reddy's Laboratories today said it has received establishment inspection report (EIR) from the US health regulator for its custom pharmaceutical services facility at Hyderabad.
The facility had undergone audit by the United States Food and Drug Administration (USFDA), Dr. Reddy's Laboratories said in a BSE filing.
The company has received EIR from the USFDA for the facility, it added.
As per USFDA, after the completion of an inspection of a facility, an EIR is issued to a company detailing inspection findings.
custom pharmaceutical services facility Dr Reddy's Dr Reddy's Laboratories Dr Reddy's Labs EIR Establishment Inspection Report Hyderabad facility indian pharma news pharma news pharma news india United States Food and Drug Administration USFDASource : PTI